network member

UPMC Hillman Cancer Center

Pittsburgh, PA
UPMC Hillman Cancer Center

About Network Member

UPMC Hillman Cancer Center is internationally recognized for its leadership in the prevention, detection, diagnosis, and treatment of cancer. Dedicated to excellence in clinical care, the performance of basic, translational, and clinical research, and the education of the next generation of cancer physicians and scientists, Hillman is well positioned to help reduce the global burden of cancer. Hillman is the only NCI-designated Comprehensive Cancer Center in western Pennsylvania and among the largest integrated cancer networks in the United States, with more than 60 locations in Pennsylvania, Ohio, and western New York. Our team of more than 2,000 physicians, researchers, and staff works collaboratively to provide each patient with the latest medical, radiation, and surgical oncology treatments, access to clinical trials, and ongoing support for the physical and emotional aspects of cancer treatment. Additionally, Hillman is proud to be a part of UPMC Presbyterian Shadyside, which is currently ranked No. 7 nationally for cancer care by U.S. News and World Report. Our investigators are leaders in cancer biology, cancer immunology and immunotherapy, cancer virology, biobehavioral cancer control, cancer epidemiology and prevention, cancer therapeutics, and genome stability. At Hillman, we are quickly advancing the latest research discoveries into pioneering therapies that can benefit the more than 113,000 patients seen each year throughout our integrated cancer care delivery network. Website: UPMC Hillman Cancer Center
Currently Enrolling

HCRN-GI23-643

Randomized Trial of Regorafenib in Combination with Pembrolizumab or Pembrolizumab Monotherapy for Patients with MSI-H Colorectal Cancer
Cancer areas:Colorectal
AdventHealth Orlando
UPMC Hillman Cancer Center
Enrollment Closed

TBCRC044

A Randomized Phase II Study of Pembrolizumab, an Anti-PD (Programmed Cell Death)-1 Antibody, in Combination With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
Cancer areas:Breast
Dana-Farber Cancer Institute
Georgetown Lombardi Comprehensive Cancer Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
The University of Chicago Medicine Comprehensive Cancer Center
UC San Francisco
UPMC Hillman Cancer Center
Vanderbilt-Ingram Cancer Center